Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.58 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.58 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.48 |
| ▸ | PDCD1LG2 | Q9BQ51 | 2/20 | 0.48 |
| ▸ | CTSD | P07339 | 2/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | VSIR | Q9H7M9 | 3/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.36 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5970526 | 1.00 | DPP4 (0.58) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL31249620 | 0.93 | DPP4 (0.51) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL31039944 | 0.91 | DPP4 (0.52) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL31688173 | 0.90 | CD274 (0.50) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL29733454 | 0.89 | BACE1 (0.49) | DPP4DPP8DPP9CD274PDCD1LG2 | |
| SCHEMBL8529159 | 0.89 | DPP4 (0.59) | DPP4DPP8DPP9BLMCD274 | |
| SCHEMBL5970284 | 0.89 | DPP4 (0.59) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL4388333 | 0.89 | DPP4 (0.59) | DPP4DPP8DPP9BLMCD274 | |
| SCHEMBL537130 | 0.89 | DPP4 (0.59) | DPP4DPP8DPP9ALOX15BLM | |
| SCHEMBL29613342 | 0.86 | DPP4 (0.48) | DPP4DPP8DPP9ALOX15BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025005815-A1 | COMPOUND, DIAGNOSTIC MARKER FOR BREAST CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR THE DIAGNOSIS OF BREAST CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF BREAST CANCER | URTESTE S.A. (PL) | 2025-01-02 | — | — | WO | claimed |
| CN-109311927-A | Sugar-dipeptides conjugates as flavor molecules | 雀巢产品技术援助有限公司 | 2019-02-05 | — | — | CN | claimed |
| WO-2016112174-A2 | Biomarkers of Sleep Deprivation and Cognitive Impairment | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2016-07-14 | — | — | WO | claimed |
| WO-2013188333-A1 | BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| WO-2026107097-A1 | SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF | ENLAZA THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-119889726-A | Semen quality prediction method and system based on random forest | 深圳市疾病预防控制中心(深圳市卫生监督局、深圳市卫生检验中心、深圳市预防医学研究所) | 2025-04-25 | — | — | CN | disclosed |
| US-12259397-B2 | Biomarkers related to organ function | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-03-25 | — | — | US | disclosed |
| US-20250025520-A1 | MICROBE-BASED MODULATION OF SEROTONIN BIOSYNTHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-01-23 | — | — | US | disclosed |
| WO-2025005815-A1 | COMPOUND, DIAGNOSTIC MARKER FOR BREAST CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR THE DIAGNOSIS OF BREAST CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF BREAST CANCER | URTESTE S.A. (PL) | 2025-01-02 | — | — | WO | disclosed |
| US-20250002594-A1 | ANTI-CD122 ANTIBODIES, ANTI-CD132 ANTIBODIES, AND RELATED BISPECIFIC BINDING PROTEINS | SHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD (CN) | 2025-01-02 | — | — | US | disclosed |
| CN-118813574-A | Application of directional mutation glycosyltransferase in synthesis of galactoside anthocyanin | 浙江大学 | 2024-10-22 | — | — | CN | disclosed |
| EP-4426742-A1 | ANTI-CD122 ANTIBODIES, ANTI-CD132 ANTIBODIES, AND RELATED BISPECIFIC BINDING PROTEINS | Shanghai Epimab Biotherapeutics Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| US-20120208215-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. (US) | 2012-08-16 | — | — | US | disclosed |
| US-8187830-B2 | Method for determining insulin sensitivity with biomarkers | METABOLON, INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090155826-A1 | Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same | METABOLON, INC. (US) | 2009-06-18 | — | — | US | disclosed |
| US-20060217321-A1 | Compositions to improve tic disorders | TAIYOKAGAKU CO., LTD. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-5919680-A | Process for the production of SSC's via expandase activity on penicillin G | ISIS INNOVATION LIMITED (GB) | 1999-07-06 | — | — | US | disclosed |
| EP-0885899-A1 | Method for obtaining peptide fragments by use of fluorinated organic acids | SEIKO INSTRUMENTS INC. (JP) | 1998-12-23 | — | — | EP | disclosed |
| EP-0863989-A2 | IMPROVED PROCESS FOR THE PRODUCTION OF SEMI-SYNTHETIC CEPHALOSPORINS VIA EXPANDASE ACTIVITY ON PENICILLIN G | GIST-BROCADES B.V. (NL) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997020053-A2 | IMPROVED PROCESS FOR THE PRODUCTION OF SEMI-SYNTHETIC CEPHALOSPORINS VIA EXPANDASE ACTIVITY ON PENICILLIN G | GIST-BROCADES B.V. (NL) | 1997-06-05 | — | — | WO | disclosed |